From: A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma
Case # | AGE | Gender | Histology Type | Site | Grade | Stage | BRAF | KRAS | CIMP | MSI-PCR | Pre-existing |
---|---|---|---|---|---|---|---|---|---|---|---|
Adenoma | |||||||||||
BRAF-1 | 60 | Male | AC | Caecum | 2 | I | V601E | Codon 13 | Low CIMP | MSI-L | Tubular adenoma |
BRAF-2 | 47 | Male | AC | Ascending colon | 2 | I | V600E | Codon 13 | NA | MSI-S | Hyperplastic polyp |
SERRATED ADENOMA | |||||||||||
BRAF-3 | 71 | Female | AC | Rt colon | 1 | III | V600E | WT | NA | MSI-H | Unremarkablemucosa |
BRAF-4 | 57 | Female | AC | Rt colon | 3 | IV | V600E | WT | Low CIMP | MSI-S | Unremarkablemucosa |
BRAF-5 | 67 | Male | AC | Recto sigmoid | 2 | II | V600E | WT | Low CIMP | MSI-S | Unremarkablemucosa |
BRAF-6 | 74 | Female | AC | Rt colon | 3 | II | V600E | WT | Low CIMP | MSI-H | Unremarkablemucosa |
BRAF-7 | 66 | Male | AC | Ascending colon | 2 | III | V594G | WT | Low CIMP | MSI-L | Adenoma |
BRAF-8 | 68 | Male | AC | Rt colon | 2 | IV | V600E | WT | Low CIMP | MSI-S | Unremarkablemucosa. |
BRAF-9 | 61 | Female | AC | Rt colon | 1 | I | V600E | WT | High CIMP | MSI-H | Small hyperplasticpolyps |
BRAF-10 | 46 | Male | AC | Sigmoid | 2 | I | V600E | WT | NA | MSI-L | Hyperplastic polyp |
BRAF-11 | 34 | Male | AC | Recto sigmoid | 2 | III | V600E | WT | Low CIMP | MSI-S | Unremarkablemucosa |
BRAF-12 | 71 | Male | AC | Sigmoid | 2 | III | V600E | WT | NA | MSI-S | Hyperplastic polyp |
BRAF-13 | 59 | Male | AC | Rectal | 2 | III | V600E | WT | High CIMP | MSI-S | Tubular adenoma |
BRAF-14 | 66 | Female | AC | Rt colon | 2 | II | V600E | WT | NA | MSI-H | Unremarkable mucosa |
BRAF-15 | 66 | Male | AC | Sigmoid colon | 2 | II | V600E | WT | Low CIMP | MSI-S | No colonic mucosa seen |
BRAF-16 | 73 | Female | AC | Rt colon | 3 | II | V600E | WT | High CIMP | MSI-H | Unremarkable mucosa |
BRAF-17 | 72 | Male | AC | Rt colon | 2 | II | V600E | WT | High CIMP | MSI-H | Unremarkable mucosa |
BRAF-18 | 74 | Female | AC | Sigmoid colon | 2 | II | V600E | WT | NA | MSI-L | Unremarkable mucosa |
BRAF-19 | 55 | Female | MC | Recto sigmoid | 2 | III | V600E | WT | NA | MSI-L | Unremarkable mucosa |